Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Down 98% since 2018, even as revs have INCREASED—precisely the OPPOSITE of the direction PPS should be going in. This week will mark one YEAR since trial concluded—and still no publication. Training of docs on CaverStem/FemCelz continues at a GLACIAL pace: according to my best reckoning of the revs vs. COGS, under 50 procedures were performed during the entire QUARTER that ended on 6/30/2019. What a farce. Where’s the beef?

Again, I MUST ask this question until it gets answered: whose interest is advanced by having the PPS of a company with revenues and now roughly break even on earnings/share THIS DAMN LOW? What is the logic?